Merlin Nexus
North America, New York, United States, New York
Description
Merlin Nexus, based in New York, is a company focused on crossover private equity investing in the life sciences industry.
Investor Profile
Merlin Nexus has backed more than 7 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series A, Series E rounds (top funding stages).
- Majority of deals are located in United States, Canada, United Kingdom.
- Strong thematic focus on Biotechnology, Therapeutics, Health Care.
Stage Focus
- Post Ipo Equity (57%)
- Series A (29%)
- Series E (14%)
Country Focus
- United States (57%)
- Canada (29%)
- United Kingdom (14%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Therapeutics
- Health Care
- Pharmaceutical
- Medical
- Biopharma
- Oncology
- Genetics
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
